DNA Kelas A Ginkgo Bioworks Holdings, Inc. Class A Common Stock
NYSE · Life Sciences Tools & Services · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 6, 2026
$12,35
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$5,37rendah 52m
$17,58tinggi 52m
Kapitalisasi Pasar (MRQ)
$787M
P/E
-2.3
EPS
$-5.64
Pendapatan
$170M
lencana Anda
Rentang 52M
$5–$18
Peringkat Analis
SELL
Target Harga
$7
P/E
-2.3
ROE
-55.8%
Margin Laba Bersih
-260.0%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
DNA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$12.35
Kapitalisasi Pasar (MRQ)
$787M
P/E
-2.3
EPS
$-5.64
Pendapatan
$170M
ROE
-55.8%
Rentang 52M
$5–$18
DNA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 20 Agu 2024 | 1-for-40 | Terbalik |
Tentang Ginkgo Bioworks Holdings, Inc. Class A Common Stock Tinjauan perusahaan dari Wikipedia
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
History
In 2014, Ginkgo was the first biotechnology company to join the Y Combinator start-up accelerator program.
On 16 December 2020, it was reported that Ginkgo Bioworks would acquire the primary assets of Novogy's Microbial Engineering Platform. 2020 also saw the company acquire property worth $25 million from Marcus Partners for the construction of a new 219,000 square foot laboratory building, after razing existing structures, located in the Raymond L Flynn Marine Park. As of 2021, the company also occupied 200,000 square feet of the Innovation and Design Building (aka IDB) in the Park. Ginkgo also occupied facilities in Cambridge, where most MIT-spin outs resided at the time.
Growth of Ginkgo up to 2021 had been driven by "robust venture capital funding" and entry into the COVID-19 testing market. This included $45 million from Viking Global in 2015.
On 11 May 2021, Ginkgo Bioworks announced plans of going public through a merger with SPAC Soaring Eagle at a $17.5 billion valuation.
On 14 May 2021, Ginkgo announced its new ticker for the NYSE will be "DNA". The ticker was previously used by Genentech, who stopped using the ticker after they were acquired by Roche. Trading began on September 17, 2021. The investment management firm Baillie Gifford became the largest shareholder (15%) with the purchase of 167.75 million shares on 31 March 2022.
On 14 March 2022, it was reported that Ginkgo Bioworks signed a Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform.
On 6 June 2022, it was reported that Ginkgo Bioworks has acquired assets from real-time metabolite monitoring company, Bitome.
On 25 July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal.
On 27 July 2022, it was reported that Ginkgo Bioworks would acquire Bayer's Biologics Research & Development site, located in West Sacramento. Ginkgo will enter into a new multi-year platform collaboration with Bayer. The deal includes the integration of the R&D platform assets from Joyn Bio, a joint-venture between Leaps by Bayer investments and Ginkgo Bioworks.
On 4 October 2022, it was reported that Ginkgo Bioworks would acquire France-based adaptive laboratory evolution instruments developer Altar and California-based Circularis to strengthen capabilities in cell and gene therapy.
In October 2022, Bloomberg News reported that Ginkgo Bioworks partnered with Intelligence Advanced Research Projects Activity to create a software tool to help detect when biological organisms have been genetically engineered. The tool known as ENDAR (short for Engineered Nucleotide Detection and Ranking) could be used to provide an early warning of bioweapons and other man-made biological threats.
Fraud allegations
On 6 October 2021, a market research firm published a report accusing Ginkgo of embellishing its revenue in a complex scheme highly dependent on related-party transactions. The report prompted an inquiry into Ginkgo by the United States Department of Justice. In November 2021, Ginkgo was sued in a shareholder lawsuit alleging it misrepresented its revenue sources in statements regarding its merger with a special-purpose acquisition company. As of 2021, the company could not name a single significant product that is manufactured and sold using its organisms.
In March 2023, the former Attorney General of Louisiana launched an investigation into the officers and directors of Ginkgo.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
sektorHealthcare
industriLife Sciences Tools & Services
karyawan485
negaraUS
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$170M2019-12-31 → 2025-12-31
EPS$-5.642019-12-31 → 2025-12-31
Arus Kas Bebas$-179M2022-12-31 → 2025-12-31
Margin bersih-260.0%2022-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | DNA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -2.3rata-rata 5T ≈-49.3 | ≈-49.3 | · | · | |
| P/S (TTM) | 7.0rata-rata 5T ≈202.7 | ≈202.7 | · | · | |
| P/B (MRQ) | 1.9rata-rata 5T ≈49.7 | ≈49.7 | · | · | |
| Harga / FCF (TTM) | -4.5rata-rata 5T ≈-206.6 | ≈-206.6 | · | · | |
| Harga / Arus Kas (TTM) | -4.6rata-rata 5T ≈-242.4 | ≈-242.4 | · | · | |
| Harga / Nilai Buku Berwujud (MRQ) | 2.1rata-rata 5T ≈115.0 | ≈115.0 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | DNA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | -259.9%rata-rata 5T ≈-309.5% | ≈-309.5% | · | · | |
| EBITDA Margin (Margin EBITDA) | -185.3%rata-rata 5T ≈-309.5% | ≈-309.5% | · | · | |
| Margin Sebelum Pajak (TTM) | -264.1%rata-rata 5T ≈-306.2% | ≈-306.2% | · | · | |
| Margin Laba Bersih (TTM) | -260.0%rata-rata 5T ≈-305.1% | ≈-305.1% | · | · | |
| ROA | -25.1%rata-rata 5T ≈-48.7% | ≈-48.7% | · | · | |
| ROE | -55.8%rata-rata 5T ≈-84.1% | ≈-84.1% | · | · | |
| ROIC | -61.8%rata-rata 5T ≈-86.3% | ≈-86.3% | · | · |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | DNA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 4.6rata-rata 5T ≈6.3 | ≈6.3 | · | · | |
| Quick Ratio (Rasio Cepat) | 4.7rata-rata 5T ≈6.0 | ≈6.0 | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | DNA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | -25.1%rata-rata 5T ≈55.9% | ≈55.9% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | -29.1%rata-rata 5T ≈3.1% | ≈3.1% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 17.3% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | DNA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.1rata-rata 5T ≈0.2 | ≈0.2 | · | · | |
| Receivables Turnover (Perputaran Piutang) | 7.4rata-rata 5T ≈7.2 | ≈7.2 | · | · | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$350.8K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
2.6%
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | $-0.75 | $-0.92 | 18.4% | |
| 31 Maret 2026 | $-1.39 | $-1.09 | -27.4% | |
| 31 Des. 2025 | $-1.41 | $-1.47 | 4.1% | |
| 30 Sep. 2025 | $-1.45 | $-1.25 | -15.8% | |
| 30 Juni 2025 | $-1.10 | $-1.58 | 30.5% | |
| 31 Maret 2025 | $-1.68 | $-1.79 | 6.0% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $170M | $227M | $251M | $478M | $314M | $77M | $54M | |
| R&D Expense | $244M | $424M | $581M | $1.05B | $1.15B | $160M | $96M | |
| SG&A Expense | $183M | $246M | $385M | $1.43B | $863M | $38M | $29M | |
| Operating Expenses | $485M | $787M | $1.12B | $2.69B | $2.14B | $214M | $126M | |
| Operating Income | $-315M | $-560M | $-864M | $-2.21B | $-1.83B | $-137M | $-72M | |
| Interest Expense | · | · | $93.0K | $106.0K | $2M | $2M | $2M | |
| Other Non-op | $2M | $12M | $-29M | $88M | $-10M | $12M | · | |
| Pretax Income | $-314M | $-548M | $-893M | $-2.12B | $-1.84B | $-125M | $-120M | |
| Income Tax | $-837.0K | $-479.0K | $-71.0K | $-15M | $-1M | $2M | $22.0K | |
| Net Income | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | $-127M | $-119M | |
| EPS (Basic) | $-5.64 | $-10.54 | $-18.37 | $-50.15 | $-1.35 | $-0.10 | $-0.10 | |
| EPS (Diluted) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 | $-0.10 | $-0.10 | |
| Shares (Basic) | 55,457,676 | 51,894,639 | 48,610,507 | 41,976,537 | 1,359,849,000 | 1,274,766,915 | 1,149,000,417 | |
| Shares (Diluted) | 55,457,676 | 51,894,639 | 48,610,507 | 41,995,972 | 1,360,373,000 | 1,274,766,915 | 1,149,000,417 | |
| EBITDA | $-315M | $-560M | $-864M | $-2.21B | · | · | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167M | $562M | $944M | $1.32B | $1.55B | $381M | $495M | |
| Short-term Investments | $255M | $0 | · | · | · | · | · | |
| Receivables | $24M | $22M | $17M | $81M | $132M | $17M | · | |
| Inventory | · | · | $46.0K | $4M | $3M | $3M | · | |
| Prepaid Expense | $25M | $19M | $40M | $52M | $34M | $21M | · | |
| Other Current Assets | · | · | $362.0K | $487.0K | $698.0K | $680.0K | · | |
| Current Assets | $472M | $603M | $1.00B | $1.45B | $1.72B | $427M | · | |
| PP&E (Net) | $167M | $204M | $188M | $315M | $146M | $121M | · | |
| PP&E (Gross) | $355M | $365M | $309M | $408M | $207M | $155M | · | |
| Accum. Depreciation | $188M | $161M | $121M | $93M | $61M | $34M | · | |
| Goodwill | · | $0 | $49M | $60M | $21M | $2M | $2M | |
| Intangibles | $53M | $73M | $83M | $111M | $22M | $3M | · | |
| Other Non-current Assets | $9M | $55M | $58M | $89M | $44M | $6M | · | |
| Total Assets | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Accounts Payable | $11M | $14M | $9M | $10M | $8M | $14M | · | |
| Accrued Liabilities | · | · | · | $115M | $93M | $31M | · | |
| Short-term Debt | · | · | · | · | · | $300.0K | · | |
| Current Liabilities | $96M | $107M | $164M | $173M | $135M | $73M | · | |
| Capital Leases | $417M | $439M | $222M | $413M | $0 | · | · | |
| Other Non-current Liabilities | $23M | $17M | $24M | $31M | $36M | $3M | · | |
| Total Liabilities | $611M | $661M | $568M | $803M | $504M | $205M | · | |
| Common Stock | $6.0K | $5.0K | $5.0K | $190.0K | $161.0K | $129.0K | · | |
| Paid-in Capital | $6.66B | $6.56B | $6.39B | $6.14B | $3.80B | $929M | · | |
| Retained Earnings | $-6.15B | $-5.84B | $-5.29B | $-4.40B | $-2.30B | $-468M | · | |
| AOCI | $2M | $-2M | $1M | $-3M | $-2M | $0 | · | |
| Stockholders' Equity | $509M | $716M | $1.10B | $1.74B | $1.57B | $470M | · | |
| Liabilities + Equity | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Shares Outstanding | 58,207,298 | 54,365,785,000 | 50,032,873 | 47,299,399 | 40,284,804 | 1,288,596,000 | · |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $59M | $63M | $71M | $43M | $29M | $14M | $11M | |
| Stock-based Comp | $82M | $112M | $230M | $1.93B | $1.61B | $476.0K | $771.0K | |
| Deferred Tax | $-1M | $-936.0K | $-801.0K | $-15M | $0 | $0 | · | |
| Amort. of Intangibles | $19M | $18M | $16M | $6M | $1M | $500.0K | $500.0K | |
| Restructuring | $11M | $19M | · | · | · | · | · | |
| Operating Cash Flow | $-171M | $-320M | $-296M | $-252M | $-254M | $-136M | $-45M | |
| CapEx | $8M | $63M | $41M | $52M | $57M | $58M | $22M | |
| Investing Cash Flow | $-240M | $-62M | $-81M | $-67M | $-73M | $-67M | $-75M | |
| Stock Issued | $19M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | $408.0K | |
| Net Stock Activity | $19M | · | · | · | · | · | · | |
| Financing Cash Flow | $18M | $-2M | $-3M | $95M | $1.53B | $90M | $410M | |
| Net Change in Cash | $-393M | $-384M | $-380M | $-223M | $1.21B | $-113M | $291M | |
| Taxes Paid | $192.0K | $0 | $23.0K | $981.0K | $9M | $0 | · | |
| Free Cash Flow | $-179M | $-382M | $-336M | $-304M | · | · | · | |
| Levered FCF | · | · | $-336M | $-305M | · | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| Net Margin | -183.8% | -240.9% | -355.1% | -440.6% | · | · | · | |
| Pretax Margin | -184.3% | -241.2% | -355.1% | -444.1% | · | · | · | |
| EBITDA Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| ROA | -25.1% | -36.0% | -42.5% | -91.3% | · | · | · | |
| ROE | -55.8% | -72.3% | -76.0% | -132.4% | · | · | · | |
| ROIC | -61.8% | -78.1% | -78.8% | -126.3% | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.6 | 6.1 | 8.4 | · | · | · | |
| Quick Ratio | 4.7 | 5.4 | 5.9 | 8.1 | · | · | · | |
| Interest Coverage | · | · | -9294.7 | -20839.2 | · | · | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | |
| Receivables Turnover | 7.4 | 11.6 | 5.1 | 4.5 | · | · | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.74 | $13.17 | $0.55 | $0.92 | · | · | · | |
| Revenue / Share | $3.07 | $4.38 | $0.13 | $0.28 | · | · | · | |
| Cash Flow / Share | $-3.08 | $-6.16 | $-0.15 | $-0.15 | · | · | · | |
| Cash / Share | $2.87 | $10.33 | $0.47 | $0.70 | · | · | · | |
| EPS (TTM) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 | · | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -25.1% | -9.7% | -47.4% | 52.2% | 309.4% | · | · | |
| Revenue CAGR 3Y | -29.1% | -10.2% | 48.6% | · | · | · | · | |
| Revenue CAGR 5Y | 17.3% | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $170M | $227M | $251M | $478M | $314M | · | · | |
| Net Income TTM | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | · | · | |
| Market Cap | $484M | $534M | $135.29B | $127.90B | · | · | · | |
| P/E | -1.5 | -0.9 | -3.7 | -1.3 | -239.1 | · | · | |
| P/S | 2.8 | 2.4 | 538.0 | 267.7 | · | · | · | |
| P/B | 1.0 | 0.7 | 123.3 | 73.7 | · | · | · | |
| P / Tangible Book | 1.1 | 0.8 | 140.2 | 81.7 | 351.4 | · | · | |
| P / Cash Flow | -2.8 | -1.7 | -457.8 | -507.1 | · | · | · | |
| P / FCF | -2.7 | -1.4 | -402.3 | -420.1 | · | · | · | |
| Earnings Yield | -67.9% | -107.3% | -27.2% | -74.3% | -0.42% | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20M | $19M | $33M | $39M | $39M | $38M | $44M | $89M | $56M | $38M | $35M | $55M | $81M | $81M | $98M | $66M | |
| Cost of Revenue | $2M | $3M | · | · | $5M | $4M | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $46M | $50M | $50M | $69M | $53M | $71M | $76M | $77M | $134M | $136M | $117M | $157M | $144M | $163M | $178M | $261M | |
| SG&A Expense | $31M | $38M | $46M | $45M | $35M | $40M | $57M | $52M | $66M | $70M | $89M | $82M | $102M | $111M | $121M | $435M | |
| Operating Expenses | $79M | $91M | $104M | $129M | $97M | $119M | $147M | $144M | $279M | $216M | $213M | $342M | $265M | $296M | $329M | $721M | |
| Operating Income | $-59M | $-71M | $-71M | $-90M | $-58M | $-81M | $-104M | $-55M | $-223M | $-178M | $-178M | $-286M | $-184M | $-216M | $-231M | $-655M | |
| Other Non-op | $1M | $-5M | $-11M | $9M | $5M | $-2M | $-4M | $-2M | $6M | $12M | $-34M | $-17M | $11M | $11M | $43M | $-15M | |
| Pretax Income | $-57M | $-76M | $-81M | $-81M | $-53M | $-83M | $-108M | $-57M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-188M | $-670M | |
| Income Tax | $128.0K | $-80.0K | $-643.0K | $1.0K | $-283.0K | $88.0K | $-325.0K | $-375.0K | $190.0K | $31.0K | $-198.0K | $-22.0K | $67.0K | $82.0K | $-15M | $-28.0K | |
| Net Income | $-47M | $-83M | $-81M | $-81M | $-60M | $-91M | $-108M | $-56M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-175M | $-670M | |
| EPS (Basic) | $-0.75 | $-1.39 | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.92 | $-1.08 | $-4.23 | $-3.31 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-48.96 | $-0.41 | |
| EPS (Diluted) | · | · | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.91 | $-1.08 | $-4.23 | $-3.32 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-49.01 | $-0.41 | |
| Shares (Basic) | 62,094,356 | 59,563,454 | · | 55,633,718 | 54,858,982 | 54,241,619 | · | 52,240,559 | 51,370,029 | 50,111,460 | · | 48,770,000 | 1,933,437,000 | 1,914,963,000 | · | 1,630,911,000 | |
| Shares (Diluted) | · | · | · | 55,633,718 | 54,858,982 | 54,241,619 | · | 52,246,129 | 51,375,599 | 50,133,366 | · | 48,770,000 | 1,933,437,000 | 1,916,637,000 | · | 1,630,911,000 | |
| EBITDA | $-59M | $-71M | · | $-90M | $-66M | $-89M | · | $-55M | $-223M | $-178M | · | $-286M | $-184M | $-216M | · | $-653M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $144M | $167M | $111M | $204M | $312M | $562M | $616M | $730M | $840M | $944M | $1.05B | $1.11B | $1.21B | $1.32B | $1.30B | |
| Short-term Investments | · | · | $255M | $384M | $356M | $13M | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | $13M | $20M | $24M | $21M | $22M | $26M | $22M | $23M | $19M | $24M | · | $62M | $68M | $83M | · | $114M | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $70.0K | $391.0K | $3M | · | $6M | |
| Prepaid Expense | $17M | $16M | $25M | $22M | $26M | $20M | $19M | $22M | $34M | $38M | · | $29M | $48M | $34M | · | $38M | |
| Current Assets | $333M | $410M | $472M | $506M | $523M | $565M | $603M | $662M | $783M | $903M | · | $1.14B | $1.22B | $1.33B | · | $1.46B | |
| PP&E (Net) | $157M | $163M | $168M | $177M | $186M | $198M | $204M | $211M | $211M | $196M | · | $202M | $294M | $314M | · | $188M | |
| PP&E (Gross) | $355M | $352M | $358M | $359M | $360M | $361M | $365M | $362M | $347M | $326M | · | $322M | $413M | $421M | · | $271M | |
| Accum. Depreciation | $198M | $189M | $191M | $182M | $173M | $163M | $161M | $151M | $136M | $130M | · | $121M | $118M | $107M | · | $83M | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | $0 | $48M | $49M | $58M | $59M | $59M | $60M | $29M | |
| Intangibles | $44M | $49M | $57M | $62M | $66M | $69M | $73M | $80M | $91M | $77M | · | $100M | $105M | $109M | · | $48M | |
| Other Non-current Assets | $1M | $40M | $47M | $47M | $47M | $47M | $55M | $60M | $60M | $61M | · | $97M | $98M | $97M | · | $44M | |
| Total Assets | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Accounts Payable | $10M | $16M | $11M | $11M | $11M | $11M | $14M | $16M | $23M | $27M | · | $11M | $14M | $22M | · | $11M | |
| Current Liabilities | $73M | $80M | $96M | $115M | $97M | $116M | $107M | $114M | $166M | $169M | · | $168M | $163M | $192M | · | $125M | |
| Capital Leases | $404M | $411M | $417M | $423M | $429M | $435M | $439M | $446M | $452M | $234M | · | $404M | $411M | $404M | · | · | |
| Other Non-current Liabilities | $16M | $22M | $23M | $17M | $18M | $15M | $17M | $18M | $21M | $25M | · | $19M | $20M | $29M | · | $35M | |
| Total Liabilities | $570M | $590M | $611M | $629M | $618M | $646M | $661M | $683M | $792M | $594M | · | $774M | $788M | $810M | · | $431M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $206.0K | $202.0K | · | $198.0K | $196.0K | $194.0K | · | $165.0K | |
| Paid-in Capital | $6.70B | $6.67B | $6.66B | $6.63B | $6.60B | $6.58B | $6.56B | $6.53B | $6.51B | $6.45B | · | $6.33B | $6.28B | $6.21B | · | $5.67B | |
| Retained Earnings | $-6.28B | $-6.23B | $-6.15B | $-6.07B | $-5.99B | $-5.93B | $-5.84B | $-5.73B | $-5.67B | $-5.46B | · | $-5.08B | $-4.78B | $-4.60B | · | $-4.23B | |
| AOCI | $950.0K | $1M | $2M | $2M | $2M | $-850.0K | $-2M | $263.0K | $-2M | $-2M | · | $-3M | $-1M | $-2M | · | $-8M | |
| Stockholders' Equity | $420M | $443M | $509M | $560M | $613M | $647M | $716M | $798M | $833M | $987M | $1.10B | $1.25B | $1.50B | $1.61B | $1.74B | $1.43B | |
| Liabilities + Equity | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Shares Outstanding | 63,711,102 | 61,660,788 | 58,207,298 | 56,836,246 | 55,425,334 | 54,698,246 | 54,365,785 | 53,082,000 | 2,078,737,000 | 2,033,624,000 | 50,032,873 | 1,972,725,000 | 1,954,704,000 | 1,933,880,000 | 47,299,399 | 1,648,263,224 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $13M | $14M | $14M | $16M | $15M | $16M | $17M | $17M | $13M | $13M | $21M | $18M | $19M | $16M | $8M | |
| Stock-based Comp | $8M | $16M | $21M | $18M | $22M | $17M | $21M | $14M | $37M | $41M | $43M | $53M | $61M | $73M | $108M | $563M | |
| Amort. of Intangibles | $4M | $4M | $5M | $5M | $4M | $4M | $5M | $5M | $5M | $3M | $3M | $4M | $4M | $4M | $3M | $1M | |
| Restructuring | · | · | $706.0K | $2M | $4M | · | $-666.0K | $3M | $12M | · | · | $0 | $0 | · | · | · | |
| Operating Cash Flow | $-44M | $-47M | $-48M | $-32M | $-40M | $-52M | $-42M | $-104M | $-84M | $-89M | $-58M | $-74M | $-74M | $-91M | $-105M | $-28M | |
| CapEx | $3M | $2M | $5.0K | $0 | $38.0K | $8M | $14M | $15M | $27M | $7M | $3M | $4M | $14M | $19M | $26M | $13M | |
| Investing Cash Flow | $11M | $23M | $95M | $-73M | $-64M | $-199M | $-13M | $-10M | $-27M | $-12M | $-47M | $-3M | $-11M | $-19M | $30M | $-46M | |
| Stock Issued | · | · | $9M | $10M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $16M | $-19.0K | $8M | $10M | $-98.0K | $-207.0K | $-203.0K | $-465.0K | $-226.0K | $-845.0K | $-632.0K | $-315.0K | $-1M | $-888.0K | $98M | $-280.0K | |
| Net Change in Cash | $-17M | $-24M | $55M | $-94M | $-104M | $-250M | $-56M | $-114M | $-111M | $-102M | $-105M | $-77M | $-87M | $-111M | $24M | $-75M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Free Cash Flow | · | $-49M | · | · | · | $-59M | · | · | · | $-96M | · | · | · | $-110M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| Net Margin | -231.7% | -424.1% | · | -207.9% | -121.6% | -188.2% | · | -63.3% | -386.4% | -437.2% | · | -546.4% | -215.1% | -254.0% | · | -1007.6% | |
| Pretax Margin | -283.8% | -391.0% | · | -207.9% | -122.1% | -188.1% | · | -63.8% | -386.1% | -437.2% | · | -546.5% | -215.0% | -253.9% | · | -1007.7% | |
| EBITDA Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| ROA | -4.2% | -7.1% | · | -6.0% | -4.2% | -6.3% | · | -3.2% | -11.1% | -8.3% | · | -15.5% | -8.1% | -9.2% | · | -33.3% | |
| ROE | -9.0% | -15.2% | · | -11.9% | -8.3% | -11.1% | · | -5.5% | -18.6% | -12.8% | · | -22.5% | -11.4% | -12.9% | · | -44.8% | |
| ROIC | -14.0% | -16.1% | · | -16.1% | -10.6% | -13.8% | · | -6.9% | -26.8% | -18.0% | · | -22.9% | -12.2% | -13.4% | · | -45.5% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 5.2 | · | 4.4 | 5.4 | 4.9 | · | 5.8 | 4.7 | 5.3 | · | 6.8 | 7.5 | 6.9 | · | 11.7 | |
| Quick Ratio | 1.3 | 2.1 | · | 4.5 | 6.0 | 3.0 | · | 5.6 | 4.5 | 5.1 | · | 6.6 | 7.2 | 6.7 | · | 11.3 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.8 | · | 1.7 | 2.4 | 1.9 | · | 2.1 | 1.3 | 0.7 | · | 0.6 | 0.7 | 0.6 | · | 0.8 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.60 | $7.19 | · | $9.85 | $11.06 | $11.84 | · | $15.03 | $0.40 | $0.49 | · | $0.64 | $0.77 | $0.83 | · | $0.87 | |
| Revenue / Share | · | · | · | $0.70 | $0.90 | $0.89 | · | $1.70 | $0.03 | $0.02 | · | $0.03 | $0.04 | $42.11 | · | $0.04 | |
| Cash Flow / Share | · | · | · | · | · | $-0.95 | · | · | · | $-0.04 | · | · | · | $-47.26 | · | · | |
| Cash / Share | $1.33 | $2.33 | · | $1.95 | $3.67 | $5.71 | · | $11.61 | $0.35 | $0.41 | · | $0.53 | $0.57 | $0.62 | · | $0.79 | |
| EPS (TTM) | $-5.64 | $-5.64 | · | $-6.14 | $-5.77 | $-8.90 | · | $-20.59 | $-25.72 | $-21.58 | · | $-55.42 | $-49.62 | $-49.94 | · | $-2.40 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112M | $131M | · | $160M | $210M | $227M | · | $218M | $184M | $209M | · | $315M | $326M | $390M | · | $528M | |
| Net Income TTM | $-291M | $-304M | · | $-340M | $-315M | $-472M | · | $-651M | $-898M | $-854M | · | $-857M | $-1.22B | $-1.72B | · | $-3.53B | |
| Market Cap | $631M | $378M | · | $829M | $624M | $312M | · | $433M | $27.77B | $94.36B | · | $142.83B | $145.43B | $102.88B | · | $205.70B | |
| P/E | -1.8 | -1.1 | · | -2.4 | -1.9 | -0.6 | · | -0.4 | -0.5 | -2.2 | · | -1.3 | -1.5 | -1.1 | · | -52.0 | |
| P/S | 5.6 | 2.9 | · | 5.2 | 3.0 | 1.4 | · | 2.0 | 150.7 | 452.1 | · | 453.4 | 446.2 | 263.8 | · | 389.7 | |
| P/B | 1.5 | 0.9 | · | 1.5 | 1.0 | 0.5 | · | 0.5 | 33.3 | 95.6 | · | 114.0 | 96.7 | 64.0 | · | 143.4 | |
| P / Tangible Book | 1.7 | 1.0 | · | 1.7 | 1.1 | 0.5 | · | 0.6 | 37.4 | 109.5 | · | 130.5 | 108.6 | 71.4 | · | 151.5 | |
| P / Cash Flow | · | -8.1 | · | · | · | -6.1 | · | · | · | -1057.2 | · | · | · | -1135.8 | · | · | |
| Earnings Yield | -56.9% | -92.0% | · | -42.1% | -51.3% | -156.1% | · | -252.6% | -192.5% | -46.5% | · | -76.5% | -66.7% | -93.9% | · | -1.9% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $170M | $227M | $251M | $478M | $314M |
| Margin Operasi % | -185.3% | -246.5% | -343.8% | -462.4% | · |
| Laba Bersih | $-313M | $-547M | $-893M | $-2.10B | $-1.83B |
| EPS Dilusian | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 4.9 | 5.6 | 6.1 | 8.4 | · |
| Rasio Cepat | 4.7 | 5.4 | 5.9 | 8.1 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-179M | $-382M | $-336M | $-304M | · |
Pemilik institusional (13F) 201 pengaju · $379.7M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
201
Nilai yang dipegang
$379.7M
Posisi baru
31
Posisi yang keluar
17
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 31 (-1 vs Kuartal sebelumnya) | 17 (-12 vs Kuartal sebelumnya) | 71 (+18 vs Kuartal sebelumnya) | 37 (-5 vs Kuartal sebelumnya) | +4.5M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| BlackRock, Inc. | $42.443.568 | 4.282.903 | 11,18% | Saham |
| VIKING GLOBAL INVESTORS LP | $35.449.338 | 3.577.128 | 9,33% | Saham |
| Erste Asset Management GmbH | $25.902.147 | 2.536.939 | 6,82% | Saham |
| VANGUARD GROUP INC | $24.106.911 | 2.900.952 | 6,35% | Saham |
| BAILLIE GIFFORD & CO | $23.701.242 | 2.391.649 | 6,24% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $20.685.074 | 2.087.293 | 5,45% | Saham |
| Anchorage Capital Group, L.L.C. | $17.306.457 | 1.746.363 | 4,56% | Saham |
| Legal & General Group Plc | $16.543.944 | 1.669.419 | 4,36% | Saham |
| STATE STREET CORP | $14.591.187 | 1.472.370 | 3,84% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $12.112.753 | 1.222.016 | 3,19% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9.293.628 | 937.803 | 2,45% | Saham |
| Allianz Asset Management GmbH | $7.787.258 | 785.798 | 2,05% | Saham |
| UBS Group AG | $6.854.341 | 691.659 | 1,80% | Saham |
| MILLENNIUM MANAGEMENT LLC | $6.329.279 | 638.676 | 1,67% | Saham |
| AQR CAPITAL MANAGEMENT LLC | $6.160.304 | 621.625 | 1,62% | Saham |
| SB INVESTMENT ADVISERS (UK) LTD | $6.052.324 | 610.729 | 1,59% | Saham |
| GOLDMAN SACHS GROUP INC | $6.019.096 | 607.376 | 1,59% | Saham |
| BANK OF AMERICA CORP /DE/ | $5.409.393 | 545.852 | 1,42% | Saham |
| Prescott Group Capital Management, L.L.C. | $5.369.684 | 541.845 | 1,41% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $5.349.973 | 539.856 | 1,41% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.109.677 | 414.700 | 1,08% | Opsi beli |
| NORTHERN TRUST CORP | $4.014.948 | 405.141 | 1,06% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.910.555 | 394.607 | 1,03% | Saham |
| EXCHANGE TRADED CONCEPTS, LLC | $3.555.540 | 358.783 | 0,94% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $3.480.392 | 351.200 | 0,92% | Saham |
| TUDOR INVESTMENT CORP ET AL | $3.326.886 | 335.710 | 0,88% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $3.097.598 | 312.573 | 0,82% | Saham |
| Coastal Bridge Advisors, LLC | $2.743.256 | 276.817 | 0,72% | Saham |
| Invesco Ltd. | $2.098.175 | 211.723 | 0,55% | Saham |
| BALANCE CAPITAL PARTNERS L.P. | $1.972.179 | 199.009 | 0,52% | Saham |
| ALGERT GLOBAL LLC | $1.784.395 | 180.060 | 0,47% | Saham |
| Susquehanna Portfolio Strategies, LLC | $1.746.449 | 176.231 | 0,46% | Saham |
| Bank of New York Mellon Corp | $1.689.463 | 170.481 | 0,44% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $1.637.935 | 165.281 | 0,43% | Saham |
| PEAK6 LLC | $1.619.294 | 163.400 | 0,43% | Opsi beli |
| CAXTON ASSOCIATES LLP | $1.532.552 | 154.647 | 0,40% | Saham |
| D. E. Shaw & Co., Inc. | $1.499.938 | 151.356 | 0,39% | Saham |
| Nuveen, LLC | $1.455.234 | 146.845 | 0,38% | Saham |
| MORGAN STANLEY | $1.430.152 | 144.314 | 0,38% | Saham |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1.387.400 | 140.000 | 0,37% | Saham |
| JPMORGAN CHASE & CO | $1.368.548 | 134.040 | 0,36% | Saham |
| CITADEL ADVISORS LLC | $1.297.565 | 130.935 | 0,34% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.297.219 | 130.900 | 0,34% | Opsi jual |
| a16z Capital Management, L.L.C. | $1.075.909 | 108.568 | 0,28% | Saham |
| CITADEL ADVISORS LLC | $1.073.253 | 108.300 | 0,28% | Opsi beli |
| Numerai GP LLC | $1.036.606 | 104.602 | 0,27% | Saham |
| AMERICAN CENTURY COMPANIES INC | $974.718 | 98.357 | 0,26% | Saham |
| WOLVERINE TRADING, LLC | $964.467 | 72.900 | 0,25% | Opsi beli |
| Ensign Peak Advisors, Inc | $931.332 | 93.979 | 0,25% | Saham |
| PANAGORA ASSET MANAGEMENT INC | $803.592 | 81.089 | 0,21% | Saham |
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Reshma P. Shetty, Barry Canton | 14 Feb. 2025 | 9,50% | Amandemen | · | SEC |
| Jason Kelly ×4 pengajuan | 14 Feb. 2024 | · | Pengajuan awal | · | SEC |
| Reshma Shetty, Bartholomew Canton ×4 pengajuan | 14 Feb. 2024 | · | Pengajuan awal | · | SEC |
| VIKING GLOBAL INVESTORS LP, VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, O. ANDREAS HALVORSEN, DAVID C. OTT, ROSE S. SHABET ×3 pengajuan | 4 Maret 2022 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 17 orang dalam · 5 pejabat · 13 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Jason R Kelly | Chief Executive Officer & Founder | 28 Juli 2026 A | 316.483 | 0 | 2 | $-1.374.823 |
| Steven P. Coen | Chief Financial Officer | 21 Agu 2026 M | 51.851 | 0 | 9 | $-263.897 |
| Mark E. Dmytruk | Chief Financial Officer | 20 Mei 2025 M | 46.226 | 0 | 0 | $0 |
| Reshma P. Shetty | President & Founder | 28 Juli 2026 A | 436.422 | 0 | 3 | $-977.101 |
| Marie E. Fallon | Chief Accounting Officer | 1 Mei 2023 M | 183.010 | 0 | 0 | $0 |
| Christian O Henry | Direktur | 15 Sep. 2026 S | 19.310 | 0 | 1 | $-35.400 |
| Sri Kosuri | Direktur | 11 Juni 2026 A | 24.067 | 0 | 0 | $0 |
| Ross Fubini | Direktur | 11 Juni 2026 A | 10.822 | 0 | 0 | $0 |
| Harry Sloan | Direktur | 11 Juni 2026 A | 271.418 | 0 | 0 | $0 |
| Shyam Sankar | Direktur | 12 Juni 2025 A | 72.372 | 0 | 0 | $0 |
| Kathy Hopinkah Hannan | Direktur | 11 Juni 2025 M | 15.003 | 0 | 0 | $0 |
| Myrtle S Potter | Direktur | 11 Juni 2025 M | 10.822 | 0 | 0 | $0 |
| Arie Belldegrun | Direktur | 13 Juni 2024 A | 194.925 | 0 | 0 | $0 |
| Reshma Kewalramani | Direktur | 12 Juni 2024 M | 186.002 | 0 | 0 | $0 |
| Marijn E Dekkers | Direktur | 12 Juni 2024 M | 386.480 | 0 | 0 | $0 |
| Eagle Equity Partners III, LLC | Direktur | 16 Sep. 2021 D | 31.590.948 | 0 | 0 | $0 |
| Barry Canton | Pemilik 10% | 28 Juli 2026 A | 436.422 | 0 | 3 | $-977.101 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 25 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| THNQ · EXCHANGE TRADED CONCEPTS TRUST | 0,69% | 355.179 NS | 31 Juli 2026 | N-PORT |
| IDNA · iShares Trust | 0,31% | 115.910 SH | 11 Sep. 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 163.763 SH | 2 Okt. 2026 | Harian |
| IWC · iShares Trust | 0,08% | 160.915 SH | 11 Sep. 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 41.498 SH | 19 Agu 2026 | Harian |
| IBB · iShares Trust | 0,02% | 379.730 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,01% | 22.732 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.228.746 SH | 11 Sep. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 549.889 SH | 19 Agu 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 274.008 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,01% | 112.735 SH | 19 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,00% | 85.360 NS | 31 Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2.967 NS | 31 Juli 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,00% | 17.486 NS | 31 Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 4.528 NS | 31 Juli 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,00% | 324 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4.838 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 22.370 SH | 3 Sep. 2026 | Harian |
| ITOT · iShares Trust | 0,00% | 66.426 SH | 11 Sep. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,00% | 29.590 NS | 31 Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 5.670 NS | 31 Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 10.065 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.489.851 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.264 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 443.818 SH | 11 Sep. 2026 | Harian |
DNA Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 10 analis
JUAL
Target median
$7.00
-43,3%
0 0,0%
Beli Kuat
0 0,0%
Beli
3 30,0%
Tahan
5 50,0%
Jual
2 20,0%
Jual Kuat
Target Harga 12 Bulan
2 analis · 2026-10-03Target rata-rata $7.00 -43,3%
Di atas semua target →
Harga saat ini $12.35
Rendah$5.00
Rata-rata$7.00
Tinggi$9.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | · |
| FTRE | $1.61B | -1.6 | 1.0% | -36.2% | -171.1% | · |
| BLFS | · | -241.8 | 28.9% | · | · | · |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
| PSNL | $816M | -8.7 | -17.7% | -116.7% | -36.0% | · |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| MLAB | $489M | 73.1 | 3.4% | 2.7% | 3.7% | 63.5% |
| OABI | · | · | · | · | · | · |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Saham "Magnificent Seven" Pilihan Cathie Wood yang Diborong Sekarang
Nasdaq · 2 bulan lalu
Yahoo announces AI-powered experiences for Yahoo Finance and Yahoo Sports
Yahoo Finance · 3 bulan, 4 minggu lalu
This Warren Buffett Stock Is Beating the S&P 500 in 2026
Nasdaq · 3 bulan, 4 minggu lalu
California Attorney General mengajukan gugatan terhadap penerus 23andMe atas pelanggaran data 2023
BBC Business · 4 bulan lalu
Iklan kit usap DNA sendiri dilarang karena menyesatkan
BBC Business · 4 bulan, 2 minggu lalu
Jim Cramer tentang BillionToOne: “Saya Bilang Beli”
Yahoo Finance · 4 bulan, 2 minggu lalu
Bagaimana nyeri matahari menginspirasi cara baru untuk menyimpan energi
BBC Business · 4 bulan, 3 minggu lalu
Vendor Ganja Digugat Karena Diduga Tidak Memberi Peringatan Konsumen Tentang Risiko
ZeroHedge · 4 bulan, 3 minggu lalu
Naik 30% dalam 1 Bulan, Apakah Zcash Pembelian Lebih Baik Daripada Bitcoin?
Yahoo Finance · 5 bulan, 1 minggu lalu
SCHQ vs. TLT: DNA Obligasi Treasury yang Sama, Biaya dan Durasi yang Sangat Berbeda
Nasdaq · 5 bulan, 2 minggu lalu
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 6, 2026